Solid Biosciences (SLDB) Tops Q4 EPS by 17c

Solid Biosciences (NASDAQ: SLDB) reported Q4 EPS of ($0.53), $0.17 better than the analyst estimate of ($0.70).

For earnings history and earnings-related data on Solid Biosciences (SLDB) click here.

You May Also Be Interested In

• Trump: Reinstating The Iranian Blockade
• JPMorgan (JPM) call put ratio 1 call to 1 put into quarter results
• Trump: I recommended Lindsey Graham's sister, Darline, to serve as interim senator from great state of South Carolina.